Predictive Oncology Inc. — Director's Dealing 2017

Jan 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2017-01-26

Reporting Person: Schwartz Carl I. (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-26	Stock Options (right to buy)	$2.80	A	7143	Acquired	2026-12-31	Common Stock (7143)	Direct
2017-01-26	Stock Options (right to buy)	$2.80	A	1786	Acquired	2026-12-31	Common Stock (1786)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	66173	Direct

Footnotes

F1: Share ownership totals have been adjusted to reflect a 1 for 25 reverse stock split effected by the issuer on October 27, 2016.

F2: Option granted pursuant to agreement dated December 31, 2016, subject to certain conditions which were satisfied on January 26, 2017.